Primary Job Title SVP, Corporate and Commercial Development Primary Organization Aimmune Therapeutics
Location San Francisco Bay Area, California, United States Regions West Coast, Western US Gender Female
LinkedIn View on LinkedIn X (Twitter) View on X
Mary Rozenman is a Vice President at Longitude Capital. She focuses on investments in biotechnology.
Prior to joining Longitude Capital in 2013, Dr. Rozenman was an Associate Principal at McKinsey & Company and a leader in the Healthcare and Corporate Finance practices. At McKinsey, she served clients in the biotechnology and medical
technology industries on a variety of strategic and operational initiatives across commercial operations, research, clinical and corporate development. Dr. Rozenman also led the support of over $6 billion in healthcare transactions for McKinsey's leading private equity clients.
